Canadian Journal of Anesthesia, Vol 35, 143-148, Copyright © 1988 by Canadian Anesthesiologists' Society

ARTICLES

Naloxone infusion after prophylactic epidural morphine: effects on incidence of postoperative side-effects and quality of analgesia

JD Gowan, JB Hurtig, RA Fraser, E Torbicki and J Kitts
Department of Anaesthesia, Ottawa Civic Hospital, Ontario.

There have been conflicting reports of the value of naloxone infusions to prevent the side-effects associated with epidural morphine. In our study, 29 patients undergoing thoracotomies for pulmonary surgery received epidural morphine (0.1 mg.kg-1) shortly after induction of anaesthesia. One hour after arrival in the Recovery Room, one of four naloxone bolus and infusion sequences was administered: saline bolus followed by saline infusion; 0.4 microgram.kg-1 naloxone bolus followed by 0.4 microgram.kg-1.hr-1 naloxone infusion; 2.0 micrograms.kg-1 naloxone bolus followed by 2.0 micrograms.kg-1.hr-1 naloxone infusion; and 4.0 micrograms.kg-1 naloxone bolus followed by 4.0 micrograms.kg-1.hr-1 naloxone infusion. Although with the number of patients studied, there were no statistically significant differences among groups, clinically, there was a trend toward decreased analgesia with all three naloxone infusion doses as determined by analgesic requirements, longest analgesic-free period and visual analogue pain scores. In addition, side-effects occurred in all groups. We conclude that prophylactic naloxone, used in this manner, is not an appropriate technique for the prevention of side-effects associated with epidural morphine used for the prevention of pain after thoracotomy.

This article has been cited by other articles:

				C.-S. Yuan Methylnaltrexone Mechanisms of Action and Effects on Opioid Bowel Dysfunction and Other Opioid Adverse Effects Ann. Pharmacother., June 1, 2007; 41(6): 984 - 993. [Abstract] [Full Text] [PDF]

				S. Charuluxananan, O. Kyokong, W. Somboonviboon, A. Narasethakamol, and P. Promlok Nalbuphine Versus Ondansetron for Prevention of Intrathecal Morphine-Induced Pruritus After Cesarean Delivery Anesth. Analg., June 1, 2003; 96(6): 1789 - 1793. [Abstract] [Full Text] [PDF]

				C.-S. Yuan, G. Wei, J. F. Foss, M. O'Connor, T. Karrison, and J. Osinski Effects of Subcutaneous Methylnaltrexone on Morphine-Induced Peripherally Mediated Side Effects: A Double-Blind Randomized Placebo-Controlled Trial J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 118 - 123. [Abstract] [Full Text] [PDF]

				S. Charuluxananan, O. Kyokong, W. Somboonviboon, S. Lertmaharit, P. Ngamprasertwong, and K. Nimcharoendee Nalbuphine Versus Propofol for Treatment of Intrathecal Morphine-Induced Pruritus After Cesarean Delivery Anesth. Analg., July 1, 2001; 93(1): 162 - 165. [Abstract] [Full Text] [PDF]

				C.-S. Yuan, J. F. Foss, M. O'Connor, J. Osinski, T. Karrison, J. Moss, and M. F. Roizen Methylnaltrexone for Reversal of Constipation Due to Chronic Methadone Use: A Randomized Controlled Trial JAMA, January 19, 2000; 283(3): 367 - 372. [Abstract] [Full Text] [PDF]